Methylnaltrexone as a Method to Improve Ticagrelor Uptake in Morphine Treated STEMI Patients
Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
This study will examine the impact of the peripheral opioid antagonist methylnaltrexone on
the onset of effect of ticagrelor in morphine treated patients with ST elevation myocardial
infarction (STEMI). Half of the participants will receive methylnaltrexone, while the other
half will receive placebo.